Brent Zanke
Fundador en ArcticDX, Inc. .
Perfil
Brent Zanke is the founder of ArcticDX, Inc. where he holds the title of Director starting in 2006.
Dr. Zanke is also the founder of CTRL Therapeutics, Inc. Dr. Zanke's former job was as Director at Cross Cancer Institute.
Dr. Zanke earned a doctorate degree from the University of Toronto in 1993 and another doctorate degree from the University of Manitoba in 1983.
Cargos activos de Brent Zanke
| Empresas | Cargo | Inicio |
|---|---|---|
ArcticDX, Inc.
 ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Fundador | 10/06/2010 |
Antiguos cargos conocidos de Brent Zanke.
| Empresas | Cargo | Fin |
|---|---|---|
CTRL Therapeutics, Inc.
 CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Director Ejecutivo | - |
| Cross Cancer Institute | Director/Miembro de la Junta | - |
Formación de Brent Zanke.
| University of Toronto | Doctorate Degree |
| University of Manitoba | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
ArcticDX, Inc.
ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Health Services |
| Cross Cancer Institute | |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Brent Zanke